- Advertisement -
- Advertisement -
Thursday, August 5, 2021

Researchers ask if survivor plasma could prevent coronavirus

Survivors of COVID-19 are donating their blood plasma in droves in hopes it helps other patients recover from the coronavirus. And while the jury’s...

Confusion reigns as UN scrambles mask, virus spread advice

LONDON — It's an issue that's been argued about for months, both by experts and by people strolling through parks all over the world:...

UN health agency: Wear mask if you can’t keep your distance

The World Health Organization is broadening its recommendations for the use of masks during the coronavirus pandemic and said Friday it is now advising...

Malaria drug didn’t help virus patients, big UK study finds

Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients...

Study on safety of malaria drugs for coronavirus retracted

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were...

Can I get COVID-19 through my eyes or ears?

Can I get COVID-19 through my eyes or ears? It's possible through the eyes, but not likely through the ears. As with the nose and mouth,...

Malaria drug fails to prevent COVID-19 in a rigorous study

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test...

UK study finds minorities at higher risk of COVID-19 death

LONDON — People from ethnic minorities have died from COVID-19 in larger relative numbers in England than their white compatriots, according to a study...

Concerns mount about two studies on drugs for coronavirus

Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to...

Gilead says drug helped moderately ill coronavirus patients

A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences...
- Advertisement -

Most Popular

Subscribe to Our Newsletter

Get the latest news and expert advice straight to your inbox.